Pharmaceutical Grade Sodium Chloride Market : The Market Is Anticipated On The Rise Due To Pharmaceutical Salt Demand For The Hemodialysis And Hemofiltration Solutions Segment

Pharmaceutical Grade Sodium Chloride Market Overview

According to a recent survey conducted by ChemView Consulting, the Global Pharmaceutical Grade Sodium Chloride Market grew at a CAGR of 5.6% between 2017-2021 and is estimated to be US$ 379.8 Mn in 2022. Currently, the market is anticipated to grow at a CAGR of 6.5% and is expected to reach a valuation of US$ 712.9 Mn by 2032 end.

The production of oral rehydration salts, hemodialysis, osmotic agents, injections, and other products uses pharmaceutical-grade sodium chloride. It is in great demand since it is recognized as a pure type of medicinal salt. Pharmaceutical salt is another name for granular, white crystalline sodium chloride, commonly known as pharmaceutical sodium chloride. A stringent process control methodology is used to produce sodium chloride of the pharmaceutical grade.

Applications for pharmaceutical-grade sodium chloride include oral rehydration salts, hemodialysis, peritoneal dialysis hemofiltration solutions, and injections. As a channeling or osmotic agent, pharmaceutical-grade sodium chloride is also used. Pharmaceutical-grade sodium chloride is used in peritoneal dialysis, mechanical cleansing solutions, ORS, and other procedures.

ChemView Consulting has analyzed that oral drug delivery has generated superior outcomes for manufacturers and end-users as a route of drug administration because of its high patient compliance, cost-effectiveness, lower sterility, constraints, flexibility in the design of dosage forms, and ease of production. The need for matrix tablets is crucial for controlled and sustained-release dosage forms. Matrix pills are frequently made using sodium chloride of the pharmaceutical grade.

To stay “ahead” of your competition, request a sample @

Significant market traction is anticipated due to the pharmaceutical salt demand for the hemodialysis and hemofiltration solutions segment continuing to develop steadily. Pharmaceutical-grade sodium chloride use is expected to rise due to relatively increased rates of lifestyle-related illnesses, particularly in industrialized nations.

Segments Covered in Report

By Type:

  • API-NaCl
  • HD-NaCl

By Application:

  • Injections
  • Hemodialysis
  • Oral Rehydration Salts
  • Osmotic Agents
  • Others

By Region and Country:

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Europe (Germany, Italy, France, UK, Spain, Netherlands, Norway, Russia, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Indonesia, Thailand, Vietnam, Australia & New Zealand, Rest of Asia-Pacific)
  • Middle East (Saudi Arabia, Turkey, UAE, Rest of Middle East)
  • Africa (South Africa, Nigeria, Egypt, Rest of Africa)

Key Takeaways from the Pharmaceutical Grade Sodium Chloride Market

  • Based on the type, the hemodialysis segment is anticipated to expand over the projection period at a rate of 5.9% CAGR. The application sector is expected to dominate the hemodialysis and hemofiltration solutions segment throughout the projection period. However, due to the rising use of salt in the manufacturing of pharmaceuticals, the saline drips, and API intermediates segments are anticipated to grow steadily.
  • Based on the region, due to the availability and accessibility of the product, Asia-Pacific is predicted to have the fastest expanding market, with a market share of 54.0% throughout the projection period.

Competition Summary

Key companies covered in the market study are K + S AG, Akzonobel, Cargill, Hebei Huachen, Swiss Saltworks, Sudsalz Gmbh, Tata Chemicals, Cheetham Salt, Salinen, Dominion Salt Ltd., US Salt

For More Details, Visit Our Report Page@

Report Key Highlights and Coverage

  • Our comprehensive, data-backed, and facts-oriented report provides niche and cross-sectional analysis at global and country levels.
  • Assessment of the historical (actual data) and current market size (2017-2021), market projections (2022-2032), and CAGR.
  • The market assessment across North America, Europe, East Asia, South Asia & Pacific, Latin America, Middle East, and Africa.
  • Competitive tactical intelligence, key strategies adopted by top players, production capacity and company shares analysis, product brand surveys, and export-import analysis
  • Pricing analysis to set and benchmark your current or future offerings across each product type helps you understand whether your pricing strategy is aligned with market expectations and can be compared to market disruptions.
  • Predictions on critical supply and demand trends and technological expertise needed to address operations scalability.
  • Consumer behavior shifts and their implications for players, list of end-users, and their consumption analysis.
  • Key drivers, restraints, opportunities, and emerging trends impact market growth.
  • Value chain analysis (list of manufacturers, distributors, end-users, and average profitability margins).
  • Strategic market analysis, recommendations, and future headways on crucial winning strategies.

About ChemView Consulting

ChemView Consulting is a leading information, market intelligence, and business consulting firm serving clients worldwide in Chemical & Materials, Food & Beverage, Oil & Gas, Clean Energy & Power, and Packaging domains. In their business transformation journey, we have collaborated with global enterprises, including 70% of the largest Forbes 1000 enterprises, helping them deliver on their business ambitions. ChemView Consulting serves clients in approximately 100 countries, with its office in New York, U.S., and Pune, India.

What sets ChemView Consulting apart?

  • Full-time research experts and subject matter experts
  • In-house primary research team
  • The in-house data visualization team
  • Industry-wide network of research partners
  • Database subscriptions
  • The exclusively tailored research process

Contact Us:

ChemView Consulting
276 5th Avenue Suite 704 – 3186,
New York, NY 10001
T: +1 315 325 8157
For Sales Enquiries:
Browse Latest Market Reports: